Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051279380> ?p ?o ?g. }
- W2051279380 endingPage "II15" @default.
- W2051279380 startingPage "II4" @default.
- W2051279380 abstract "Periprocedural myonecrosis, as evidenced by elevated creatine kinase-myocardial bound (CK-MB) levels, occurs in up to 25% of patients undergoing percutaneous coronary intervention (PCI) and has been linked with an increased risk of adverse short- and long-term clinical outcomes. Such myonecrosis arises from three main pathophysiological mechanisms: procedure-related complications, lesion-specific characteristics (e.g., large thrombus burden, plaque volume), and patient-specific characteristics (e.g., genetic predisposition, arterial inflammation). Periprocedural myonecrosis has not been definitively identified as the cause of postprocedural ischemic events, although agents that reduce or prevent thrombosis--including aspirin, thienopyridines, heparin, low-molecular-weight heparins, glycoprotein IIb/IIIa inhibitors, and direct thrombin inhibitors--have been shown to reduce the incidence of ischemic outcomes in this population, as have agents that reduce inflammation (aspirin, statins). At the same time, antithrombotic agents are known to increase the risk of bleeding and the use of transfusions, which have likewise been associated with worse outcomes in these patients. Thus, optimal management of patients undergoing PCI represents a balance between minimizing the risk of ischemic outcomes and simultaneously minimizing the risk of major bleeding. It may be that patients who have only minor, untreated postprocedural elevations in CK-MB level (with no clinical or angiographic signs of ischemia) might have a better prognosis than patients who have normal CK-MB levels but who suffer major bleeding complications." @default.
- W2051279380 created "2016-06-24" @default.
- W2051279380 creator A5005986301 @default.
- W2051279380 creator A5010571732 @default.
- W2051279380 date "2007-01-01" @default.
- W2051279380 modified "2023-09-27" @default.
- W2051279380 title "Evolution of Anticoagulant and Antiplatelet Therapy: Benefits and Risks of Contemporary Pharmacologic Agents and Their Implications for Myonecrosis and Bleeding in Percutaneous Coronary Intervention" @default.
- W2051279380 cites W1798560376 @default.
- W2051279380 cites W1941211279 @default.
- W2051279380 cites W1967809001 @default.
- W2051279380 cites W1976114037 @default.
- W2051279380 cites W1979372622 @default.
- W2051279380 cites W1980600457 @default.
- W2051279380 cites W1982082084 @default.
- W2051279380 cites W1982516608 @default.
- W2051279380 cites W1986416155 @default.
- W2051279380 cites W1989104755 @default.
- W2051279380 cites W1989456091 @default.
- W2051279380 cites W1998792752 @default.
- W2051279380 cites W2002525608 @default.
- W2051279380 cites W2013537866 @default.
- W2051279380 cites W2023626860 @default.
- W2051279380 cites W2027799480 @default.
- W2051279380 cites W2031185570 @default.
- W2051279380 cites W2035542600 @default.
- W2051279380 cites W2039785113 @default.
- W2051279380 cites W2049486997 @default.
- W2051279380 cites W2049557830 @default.
- W2051279380 cites W2052443929 @default.
- W2051279380 cites W2053379248 @default.
- W2051279380 cites W2057172700 @default.
- W2051279380 cites W2058163722 @default.
- W2051279380 cites W2058848475 @default.
- W2051279380 cites W2061635604 @default.
- W2051279380 cites W2064020544 @default.
- W2051279380 cites W2064226555 @default.
- W2051279380 cites W2067932320 @default.
- W2051279380 cites W2069635552 @default.
- W2051279380 cites W2070257700 @default.
- W2051279380 cites W2071330170 @default.
- W2051279380 cites W2072386538 @default.
- W2051279380 cites W2073389817 @default.
- W2051279380 cites W2073406816 @default.
- W2051279380 cites W2078113728 @default.
- W2051279380 cites W2081799397 @default.
- W2051279380 cites W2084673482 @default.
- W2051279380 cites W2085897604 @default.
- W2051279380 cites W2087914195 @default.
- W2051279380 cites W2089019235 @default.
- W2051279380 cites W2096002945 @default.
- W2051279380 cites W2098044998 @default.
- W2051279380 cites W2098885552 @default.
- W2051279380 cites W2099409915 @default.
- W2051279380 cites W2099751650 @default.
- W2051279380 cites W2100800328 @default.
- W2051279380 cites W2102300355 @default.
- W2051279380 cites W21063540 @default.
- W2051279380 cites W2109609988 @default.
- W2051279380 cites W2110385373 @default.
- W2051279380 cites W2112166008 @default.
- W2051279380 cites W2112205428 @default.
- W2051279380 cites W2113344414 @default.
- W2051279380 cites W2117066191 @default.
- W2051279380 cites W2118209704 @default.
- W2051279380 cites W2121251309 @default.
- W2051279380 cites W2121293226 @default.
- W2051279380 cites W2124064820 @default.
- W2051279380 cites W2124988683 @default.
- W2051279380 cites W2129750583 @default.
- W2051279380 cites W2130652855 @default.
- W2051279380 cites W2130879131 @default.
- W2051279380 cites W2135653600 @default.
- W2051279380 cites W2136473335 @default.
- W2051279380 cites W2138733869 @default.
- W2051279380 cites W2141117188 @default.
- W2051279380 cites W2141192690 @default.
- W2051279380 cites W2145123374 @default.
- W2051279380 cites W2145710740 @default.
- W2051279380 cites W2145869590 @default.
- W2051279380 cites W2147195562 @default.
- W2051279380 cites W2147294426 @default.
- W2051279380 cites W2149599987 @default.
- W2051279380 cites W2155598961 @default.
- W2051279380 cites W2159449551 @default.
- W2051279380 cites W2160152341 @default.
- W2051279380 cites W2160395675 @default.
- W2051279380 cites W2161043271 @default.
- W2051279380 cites W2172144525 @default.
- W2051279380 cites W22056812 @default.
- W2051279380 cites W2224057980 @default.
- W2051279380 cites W2230838014 @default.
- W2051279380 cites W2277227801 @default.
- W2051279380 cites W2315322366 @default.
- W2051279380 cites W2316166446 @default.
- W2051279380 cites W2316460201 @default.
- W2051279380 cites W2325460018 @default.
- W2051279380 cites W2327850977 @default.
- W2051279380 cites W2750358560 @default.